Cytosorbents (CTSO) Total Non-Current Liabilities (2010 - 2017)

Cytosorbents' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $13.1 million for Q2 2017.

• Quarterly Total Non-Current Liabilities rose 87.33% year-over-year to $13.1 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $13.1 million (up 87.33% YoY) and the FY2016 annual result came in at $6.5 million, up 364.95% from the prior year.
• Total Non-Current Liabilities was $13.1 million for Q2 2017 at Cytosorbents, up from $8.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $13.1 million in Q2 2017 and bottomed at $1.4 million in Q4 2015.
• A 4-year average of $7.1 million and a median of $7.1 million in 2016 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2015 — Total Non-Current Liabilities plunged 74.35% — and 2016, when it surged 364.95%.
• Cytosorbents' Total Non-Current Liabilities stood at $5.5 million in 2014, then plunged by 74.35% to $1.4 million in 2015, then jumped by 364.95% to $6.5 million in 2016, then surged by 100.53% to $13.1 million in 2017.
• Business Quant data shows CTSO's Total Non-Current Liabilities at $13.1 million in Q2 2017, $8.2 million in Q1 2017, and $6.5 million in Q4 2016.